about
Adoptive immunotherapy against ovarian cancerT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?The role of tumor microenvironment in therapeutic resistanceCrosstalk in skin: melanocytes, keratinocytes, stem cells, and melanomaImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesNovel immunotherapy in metastatic renal cell carcinoma.Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.Immunotherapy of cancers comes of age.Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.The new era of nanotechnology, an alternative to change cancer treatment.Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy.Application of Genome Editing Techniques in Immunology.Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.Immunotherapeutics for the treatment of prostate cancer: a patent landscape based on key therapeutic mechanisms of actions.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept.Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.Immuno-Oncology: Emerging Targets and Combination TherapiesChallenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineImpact of curative radiotherapy on the immune status of patients with localized prostate cancerSurface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesSelection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology"
P2860
Q26748905-3FC1A9BA-0B02-46D6-BA81-62A94D46966AQ27335110-234477B8-8F5C-4091-AD2F-5E0188F03C78Q28069049-FE897D13-0D8C-4A11-B1E4-31817625AF9BQ28072599-932E6A40-5C30-4BAB-B987-7D60E8C190FBQ28079180-A65D407F-0CD7-4465-8E2B-C89499C3521EQ33863074-0EC8AE84-6204-45EA-A1B0-005A3D395398Q38796338-7C03F8F7-4C3F-4D46-ADE0-7DEA248A1107Q40099075-984F0F02-E5AC-43E9-AD46-F96B47AC3E66Q40108146-AE91B4EE-2299-437A-A104-8ABCF5593B94Q42370576-B35DB7CA-A146-4F30-87FE-935178EDB2A1Q42372848-76CEC547-0971-4440-99DD-7FC1960CBF66Q47482062-62415DBE-ACCB-48CC-8DDF-F86848ECEBD6Q49679692-E40F6070-0B29-434E-A3E6-C16EC390A210Q49951814-D142EE8A-3DC7-4B35-9DAA-FC763D92E7FAQ50426810-420BF60D-99DA-4489-89A1-D62A44726301Q52358306-D2BBDA45-4615-4609-BCEC-9125BECDC2DBQ55085319-7FC4310F-DF9B-445E-A2DC-D2941BB7D4CFQ56889817-41933D32-A1F1-41E9-8EB1-80291B7CAE22Q57171377-7305ED69-56BC-4F22-AA5B-971043AFF196Q58564319-A92F5B39-EE04-42B7-BD41-0E8B0AC08892Q58726929-4C9EC3C1-B4D3-4E27-9E1C-18E802226CE8Q58767543-5209B2FC-AF7F-4344-9FF6-1BDCEEEC2204
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adoptive T cell immunotherapy for cancer.
@ast
Adoptive T cell immunotherapy for cancer.
@en
type
label
Adoptive T cell immunotherapy for cancer.
@ast
Adoptive T cell immunotherapy for cancer.
@en
prefLabel
Adoptive T cell immunotherapy for cancer.
@ast
Adoptive T cell immunotherapy for cancer.
@en
P2093
P2860
P356
P1476
Adoptive T cell immunotherapy for cancer
@en
P2093
Jonathan Schneck
Juan Carlos Varela
Mathias Oelke
P2860
P356
10.5041/RMMJ.10179
P407
P50
P577
2015-01-29T00:00:00Z